HEADER SIGNALING PROTEIN 11-JUL-22 8DNJ TITLE CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND WITH ASTRAZENECA TITLE 2 WO2020/178282A1 COMPOUND 76 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2B OF GTPASE KRAS; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: K-RAS 2,KI-RAS,C-K-RAS,C-KI-RAS; COMPND 5 EC: 3.6.5.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: G12C VARIANT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 VARIANT: VAR_006839 G12C; SOURCE 6 GENE: KRAS, KRAS2, RASK2; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, GTPASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.MOHR REVDAT 3 18-OCT-23 8DNJ 1 REMARK REVDAT 2 05-OCT-22 8DNJ 1 JRNL REVDAT 1 17-AUG-22 8DNJ 0 JRNL AUTH K.ZHU,C.LI,K.Y.WU,C.MOHR,X.LI,B.LANMAN JRNL TITL MODELING RECEPTOR FLEXIBILITY IN THE STRUCTURE-BASED DESIGN JRNL TITL 2 OF KRAS G12C INHIBITORS. JRNL REF J.COMPUT.AIDED MOL.DES. V. 36 591 2022 JRNL REFN ESSN 1573-4951 JRNL PMID 35930206 JRNL DOI 10.1007/S10822-022-00467-0 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC V5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 40836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2186 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4034 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 177 REMARK 3 SOLVENT ATOMS : 199 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.32000 REMARK 3 B22 (A**2) : -2.20000 REMARK 3 B33 (A**2) : 3.47000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.21000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.193 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 8DNJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000264971. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS V1.14.13 REMARK 200 DATA SCALING SOFTWARE : XIA2 V0.5.092 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43236 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 112.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER V2.8.3 REMARK 200 STARTING MODEL: 6OIM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.001M MGCL2, 0.1 M MES PH 6.5, 30% REMARK 280 PEG 4000, 10% ETHANOL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.08100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 LYS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PRO A -3 REMARK 465 ARG A -2 REMARK 465 LYS A 169 REMARK 465 MET B -14 REMARK 465 LYS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 LEU B -5 REMARK 465 VAL B -4 REMARK 465 PRO B -3 REMARK 465 ARG B -2 REMARK 465 GLY B -1 REMARK 465 GLU B 168 REMARK 465 LYS B 169 REMARK 465 MET C -14 REMARK 465 LYS C -13 REMARK 465 HIS C -12 REMARK 465 HIS C -11 REMARK 465 HIS C -10 REMARK 465 HIS C -9 REMARK 465 HIS C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 LEU C -5 REMARK 465 VAL C -4 REMARK 465 PRO C -3 REMARK 465 ARG C -2 REMARK 465 LYS C 167 REMARK 465 GLU C 168 REMARK 465 LYS C 169 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 149 -5.61 87.33 REMARK 500 ARG A 149 -5.70 87.34 REMARK 500 ARG B 149 -3.11 83.45 REMARK 500 ASP C 105 -7.75 77.01 REMARK 500 LYS C 117 30.12 74.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 17 OG REMARK 620 2 GDP A 302 O2B 86.1 REMARK 620 3 HOH A 401 O 92.8 83.2 REMARK 620 4 HOH A 405 O 79.7 94.8 172.4 REMARK 620 5 HOH A 414 O 172.9 87.6 89.7 97.5 REMARK 620 6 HOH A 431 O 93.1 172.9 89.9 92.0 93.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 17 OG REMARK 620 2 GDP B 302 O2B 85.9 REMARK 620 3 HOH B 401 O 80.9 95.7 REMARK 620 4 HOH B 413 O 91.3 83.8 172.2 REMARK 620 5 HOH B 417 O 173.5 88.7 96.1 91.7 REMARK 620 6 HOH B 425 O 93.0 171.0 92.9 87.4 92.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER C 17 OG REMARK 620 2 GDP C 302 O2B 88.5 REMARK 620 3 HOH C 402 O 81.1 86.5 REMARK 620 4 HOH C 407 O 88.0 92.9 169.0 REMARK 620 5 HOH C 414 O 90.7 179.2 93.6 86.8 REMARK 620 6 HOH C 427 O 175.7 92.1 94.7 96.2 88.7 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8DNI RELATED DB: PDB DBREF 8DNJ A 1 169 UNP P01116-2 RASK_HUMAN 1 169 DBREF 8DNJ B 1 169 UNP P01116-2 RASK_HUMAN 1 169 DBREF 8DNJ C 1 169 UNP P01116-2 RASK_HUMAN 1 169 SEQADV 8DNJ MET A -14 UNP P01116-2 INITIATING METHIONINE SEQADV 8DNJ LYS A -13 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -12 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -11 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -10 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -9 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -8 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -7 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS A -6 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ LEU A -5 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ VAL A -4 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ PRO A -3 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ ARG A -2 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ GLY A -1 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ SER A 0 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ CYS A 12 UNP P01116-2 GLY 12 VARIANT SEQADV 8DNJ SER A 51 UNP P01116-2 CYS 51 ENGINEERED MUTATION SEQADV 8DNJ LEU A 80 UNP P01116-2 CYS 80 ENGINEERED MUTATION SEQADV 8DNJ SER A 118 UNP P01116-2 CYS 118 ENGINEERED MUTATION SEQADV 8DNJ MET B -14 UNP P01116-2 INITIATING METHIONINE SEQADV 8DNJ LYS B -13 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -12 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -11 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -10 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -9 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -8 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -7 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS B -6 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ LEU B -5 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ VAL B -4 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ PRO B -3 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ ARG B -2 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ GLY B -1 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ SER B 0 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ CYS B 12 UNP P01116-2 GLY 12 VARIANT SEQADV 8DNJ SER B 51 UNP P01116-2 CYS 51 ENGINEERED MUTATION SEQADV 8DNJ LEU B 80 UNP P01116-2 CYS 80 ENGINEERED MUTATION SEQADV 8DNJ SER B 118 UNP P01116-2 CYS 118 ENGINEERED MUTATION SEQADV 8DNJ MET C -14 UNP P01116-2 INITIATING METHIONINE SEQADV 8DNJ LYS C -13 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -12 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -11 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -10 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -9 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -8 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -7 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ HIS C -6 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ LEU C -5 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ VAL C -4 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ PRO C -3 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ ARG C -2 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ GLY C -1 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ SER C 0 UNP P01116-2 EXPRESSION TAG SEQADV 8DNJ CYS C 12 UNP P01116-2 GLY 12 VARIANT SEQADV 8DNJ SER C 51 UNP P01116-2 CYS 51 ENGINEERED MUTATION SEQADV 8DNJ LEU C 80 UNP P01116-2 CYS 80 ENGINEERED MUTATION SEQADV 8DNJ SER C 118 UNP P01116-2 CYS 118 ENGINEERED MUTATION SEQRES 1 A 184 MET LYS HIS HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG SEQRES 2 A 184 GLY SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA SEQRES 3 A 184 CYS GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE SEQRES 4 A 184 GLN ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU SEQRES 5 A 184 ASP SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR SEQRES 6 A 184 SER LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU SEQRES 7 A 184 TYR SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU SEQRES 8 A 184 GLY PHE LEU LEU VAL PHE ALA ILE ASN ASN THR LYS SER SEQRES 9 A 184 PHE GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG SEQRES 10 A 184 VAL LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY SEQRES 11 A 184 ASN LYS SER ASP LEU PRO SER ARG THR VAL ASP THR LYS SEQRES 12 A 184 GLN ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE SEQRES 13 A 184 ILE GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP SEQRES 14 A 184 ALA PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS SEQRES 15 A 184 GLU LYS SEQRES 1 B 184 MET LYS HIS HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG SEQRES 2 B 184 GLY SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA SEQRES 3 B 184 CYS GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE SEQRES 4 B 184 GLN ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU SEQRES 5 B 184 ASP SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR SEQRES 6 B 184 SER LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU SEQRES 7 B 184 TYR SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU SEQRES 8 B 184 GLY PHE LEU LEU VAL PHE ALA ILE ASN ASN THR LYS SER SEQRES 9 B 184 PHE GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG SEQRES 10 B 184 VAL LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY SEQRES 11 B 184 ASN LYS SER ASP LEU PRO SER ARG THR VAL ASP THR LYS SEQRES 12 B 184 GLN ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE SEQRES 13 B 184 ILE GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP SEQRES 14 B 184 ALA PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS SEQRES 15 B 184 GLU LYS SEQRES 1 C 184 MET LYS HIS HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG SEQRES 2 C 184 GLY SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA SEQRES 3 C 184 CYS GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE SEQRES 4 C 184 GLN ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU SEQRES 5 C 184 ASP SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR SEQRES 6 C 184 SER LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU SEQRES 7 C 184 TYR SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU SEQRES 8 C 184 GLY PHE LEU LEU VAL PHE ALA ILE ASN ASN THR LYS SER SEQRES 9 C 184 PHE GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG SEQRES 10 C 184 VAL LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY SEQRES 11 C 184 ASN LYS SER ASP LEU PRO SER ARG THR VAL ASP THR LYS SEQRES 12 C 184 GLN ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE SEQRES 13 C 184 ILE GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP SEQRES 14 C 184 ALA PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS SEQRES 15 C 184 GLU LYS HET MG A 301 1 HET GDP A 302 28 HET U4U A 303 30 HET MG B 301 1 HET GDP B 302 28 HET U4U B 303 30 HET MG C 301 1 HET GDP C 302 28 HET U4U C 303 30 HETNAM MG MAGNESIUM ION HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM U4U 1-[(5S,9P,12AR)-9-(2-CHLORO-6-HYDROXYPHENYL)-8-ETHYNYL- HETNAM 2 U4U 10-FLUORO-3,4,12,12A-TETRAHYDRO-6H-PYRAZINO[2,1-C][1, HETNAM 3 U4U 4]BENZOXAZEPIN-2(1H)-YL]PROPAN-1-ONE FORMUL 4 MG 3(MG 2+) FORMUL 5 GDP 3(C10 H15 N5 O11 P2) FORMUL 6 U4U 3(C23 H22 CL F N2 O3) FORMUL 13 HOH *199(H2 O) HELIX 1 AA1 GLY A 15 ASN A 26 1 12 HELIX 2 AA2 SER A 65 GLY A 75 1 11 HELIX 3 AA3 ASN A 86 ASP A 92 1 7 HELIX 4 AA4 ASP A 92 ASP A 105 1 14 HELIX 5 AA5 ASP A 126 TYR A 137 1 12 HELIX 6 AA6 GLY A 151 GLU A 168 1 18 HELIX 7 AA7 GLY B 15 ASN B 26 1 12 HELIX 8 AA8 SER B 65 GLY B 75 1 11 HELIX 9 AA9 ASN B 86 ASP B 105 1 20 HELIX 10 AB1 ASP B 126 GLY B 138 1 13 HELIX 11 AB2 GLY B 151 LYS B 167 1 17 HELIX 12 AB3 GLY C 15 ASN C 26 1 12 HELIX 13 AB4 SER C 65 GLY C 75 1 11 HELIX 14 AB5 ASN C 86 ASP C 92 1 7 HELIX 15 AB6 ASP C 92 ASP C 105 1 14 HELIX 16 AB7 ASP C 126 GLY C 138 1 13 HELIX 17 AB8 GLY C 151 HIS C 166 1 16 SHEET 1 AA1 6 SER A 39 ILE A 46 0 SHEET 2 AA1 6 GLU A 49 ASP A 57 -1 O LEU A 53 N LYS A 42 SHEET 3 AA1 6 SER A 0 VAL A 9 1 N LEU A 6 O ASP A 54 SHEET 4 AA1 6 SER C 0 VAL C 9 -1 O MET C 1 N MET A 1 SHEET 5 AA1 6 GLU C 49 ASP C 57 1 O LEU C 56 N VAL C 8 SHEET 6 AA1 6 ASP C 38 ILE C 46 -1 N TYR C 40 O ILE C 55 SHEET 1 AA2 8 PHE A 141 GLU A 143 0 SHEET 2 AA2 8 MET A 111 ASN A 116 1 N LEU A 113 O ILE A 142 SHEET 3 AA2 8 GLY A 77 ALA A 83 1 N PHE A 82 O ASN A 116 SHEET 4 AA2 8 SER A 0 VAL A 9 1 N VAL A 9 O VAL A 81 SHEET 5 AA2 8 SER C 0 VAL C 9 -1 O MET C 1 N MET A 1 SHEET 6 AA2 8 GLY C 77 ALA C 83 1 O VAL C 81 N VAL C 9 SHEET 7 AA2 8 MET C 111 ASN C 116 1 O ASN C 116 N PHE C 82 SHEET 8 AA2 8 PHE C 141 GLU C 143 1 O ILE C 142 N LEU C 113 SHEET 1 AA3 6 SER B 39 ILE B 46 0 SHEET 2 AA3 6 GLU B 49 ASP B 57 -1 O SER B 51 N VAL B 44 SHEET 3 AA3 6 THR B 2 VAL B 9 1 N LEU B 6 O ASP B 54 SHEET 4 AA3 6 GLY B 77 ALA B 83 1 O LEU B 79 N VAL B 9 SHEET 5 AA3 6 MET B 111 ASN B 116 1 O VAL B 114 N LEU B 80 SHEET 6 AA3 6 PHE B 141 GLU B 143 1 O ILE B 142 N LEU B 113 LINK SG CYS A 12 C22 U4U A 303 1555 1555 1.81 LINK SG CYS B 12 C22 U4U B 303 1555 1555 1.81 LINK SG CYS C 12 C22 U4U C 303 1555 1555 1.81 LINK OG SER A 17 MG MG A 301 1555 1555 2.18 LINK MG MG A 301 O2B GDP A 302 1555 1555 2.18 LINK MG MG A 301 O HOH A 401 1555 1555 2.18 LINK MG MG A 301 O HOH A 405 1555 1555 2.17 LINK MG MG A 301 O HOH A 414 1555 1555 2.17 LINK MG MG A 301 O HOH A 431 1555 1555 2.17 LINK OG SER B 17 MG MG B 301 1555 1555 2.18 LINK MG MG B 301 O2B GDP B 302 1555 1555 2.17 LINK MG MG B 301 O HOH B 401 1555 1555 2.17 LINK MG MG B 301 O HOH B 413 1555 1555 2.17 LINK MG MG B 301 O HOH B 417 1555 1555 2.17 LINK MG MG B 301 O HOH B 425 1555 1555 2.17 LINK OG SER C 17 MG MG C 301 1555 1555 2.18 LINK MG MG C 301 O2B GDP C 302 1555 1555 2.17 LINK MG MG C 301 O HOH C 402 1555 1555 2.17 LINK MG MG C 301 O HOH C 407 1555 1555 2.17 LINK MG MG C 301 O HOH C 414 1555 1555 2.18 LINK MG MG C 301 O HOH C 427 1555 1555 2.17 CRYST1 37.594 112.162 57.821 90.00 96.80 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026600 0.000000 0.003174 0.00000 SCALE2 0.000000 0.008916 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017417 0.00000